NPI registry status
Active
2026 NPPES data Endocrinology, Diabetes & Metabolism Physician NPI 1306841952 M.D.
Verify on CMS → Mark Campbell, M.D.
Endocrinology, Diabetes & Metabolism Physician in Altoona, Pennsylvania.
This profile is drawn from the federal National Provider Identifier Registry (CMS NPPES), which lists more than 7 million U.S. healthcare providers - including 7,852 in Endocrinology, Diabetes & Metabolism Physician, and covers specialty classification, practice address, and Medicare Part D prescribing data when reported. According to CMS, every field reflects the provider's official federal registration, see our methodology.
Federal data, no proprietary rating.
We show these CMS records as-is - no composite score, no star rating, no editorial opinion layered on top.
Prescribing volume
4K
Medicare Part D claims · 398 beneficiaries · Endocrinology, Diabetes & Metabolism Physician avg: 3K
Generic prescribing
46%
generic claims · 48% brand-name · higher generic rates reduce patient out-of-pocket costs
Industry payments
$1.1K
53 payments · CMS Open Payments (Sunshine Act)
Source: CMS Medicare Part D Prescriber Public Use File, 2023
Compiled from official public sources by the PlainDoctor editorial team.
What the federal data shows
Mark Campbell, M.D. filed 4,176 Medicare Part D claims in 2023 as a Endocrinology, Diabetes & Metabolism Physician in Altoona, Pennsylvania, prescribing 46% generic.
- 4K
- Part D claims, 2023
- 46%
- generic prescribing
- $1.1K
- industry payments (Sunshine Act)
Every figure on this page comes straight from federal CMS records (NPPES, Medicare Part D, MIPS, Open Payments) - no proprietary rating or editorial opinion is applied.
Mark Campbell, M.D.'s Medicare Part D volume vs every U.S. prescriber
Total Medicare Part D claims, 2023, across all CMS prescribers nationally
4,176 Top 8% higher than 92% of 1,370,886 prescribers
Each bar is a band; taller bars hold more prescribers. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count, share, and where it sits relative to this entry.
Source CMS Medicare Part D Prescriber Public Use File · 2023
◑
Board-eligible specialty (heuristic, not verified)
Mark Campbell, M.D. practices in an ABMS-board-eligible specialty but we don't have enough CMS-participation signals to confirm active board-certified status. Consult CertificationMatters.org (the official ABMS public lookup).
What does the federal data show about Mark Campbell, M.D.?
Quality data not reportedPrimary specialty
Endocrinology, Diabetes & Metabolism Physician
Medicare Part D claims
4,176 58% vs specialty avg
Specialty distribution in Pennsylvania
How Endocrinology, Diabetes & Metabolism Physician compares to other specialties among Pennsylvania providers
Board certification
Not published by CMS
CMS does not publish a per-provider board-certification field in NPPES. PlainDoctor does not have a reliable per-specialty certification rate to show for Endocrinology, Diabetes & Metabolism Physician. Verify directly:
How MIPS and board certification work
The Merit-based Incentive Payment System (MIPS) scores providers 0–100 across four performance categories: Quality, Cost, Promoting Interoperability, and Improvement Activities, weighted under 42 CFR §414.1380. Reporting is voluntary for many small practices, so absence of a MIPS score is not a quality signal.
Board certification through an ABMS or AOA member board signals voluntary post-licensure examination plus continuous Maintenance of Certification cycles. Verify any individual provider's status through certificationmatters.org (ABMS) or osteopathic.org (AOA).
Mark Campbell, M.D. appears in the CMS NPPES registry as a Endocrinology, Diabetes & Metabolism Physician provider holding M.D. credentials at 615 HOWARD AVE, Altoona, PA, 16601, with a listed phone of (814) 949-2950. NPI 1306841952 was issued on 06/20/2005.
Medicare Part D records for calendar year 2023 show 4,176 prescription claims written by this provider, covering 398 Medicare beneficiaries and totaling roughly $1.6 million in drug spend, split 48% brand-name and 46% generic by claim count.
Endocrinology, Diabetes & Metabolism Physician is a mid-sized specialty nationwide, with 7,852 enrolled providers across 54 states and an average of 2,639 Part D claims per prescriber, so the context for interpreting these metrics differs meaningfully from a primary-care baseline.
Important: PlainDoctor is a directory of publicly available government data, not medical advice, a malpractice database, or a quality rating. Inclusion here does not imply a recommendation, and absence of complaints or sanctions on this page does not mean none exist, always verify credentials through the NPPES NPI Registry, your state medical board, and the ABMS or AOA before making healthcare decisions.
Practice Address
Provider Details
| NPI | 1306841952 |
|---|---|
| Specialty | Endocrinology, Diabetes & Metabolism Physician |
| Credentials | M.D. |
| Gender | Male |
| NPI Issued | 06/20/2005 |
Industry payments received (2024) - CMS Open Payments transparency data
The federal Physician Payments Sunshine Act (part of the Affordable Care Act) requires drug and medical-device manufacturers + group purchasing organizations to publicly report payments and other transfers of value to physicians and teaching hospitals. The data below covers 2024 for Mark Campbell, M.D.. Source: openpaymentsdata.cms.gov.
Total received
$1.1K
Largest payer
Corcept Therapeutics
Most common payment type
Food and Beverage
Industry payments are not necessarily indicators of bias, they include research funding, consulting fees for evidence-based work, royalties for inventions, food at conferences, and similar items. The disclosure exists for transparency. Read our methodology for how we interpret this data.
License & disciplinary context - Pennsylvania PA-BOM 2023 annual report
Aggregate state board data only, NOT a determination of any individual provider's status. The figures below describe statewide disciplinary activity across all ~45K Pennsylvania medical licensees in 2023 - they are NOT specific to Mark Campbell, M.D.. To verify Mark Campbell, M.D.'s current license status, search the PA-BOM public license lookup directly, or check the Federation of State Medical Boards (FSMB) verification service.
133
Total board actions, Pennsylvania 2023
Across 129 cases
2.96
Actions per 1,000 licensees
Pennsylvania statewide rate
probation
Most common action type
48 cases
PA-BOM publishes annual disciplinary statistics as part of public-record reporting under each state's Administrative Procedure Act. See the full breakdown by action type and year on the Pennsylvania disciplinary trends page. Cross-checked against FSMB U.S. Medical Regulatory Trends.
Brand vs generic prescribing mix · Above average
Mark Campbell, M.D. - brand share 48.0%
Endocrinology, Diabetes & Metabolism Physician average
48% brand-name claims vs 46% generic, on 4,176 2023 Medicare Part D claims.
The federal Medicare Part D Generic Dispensing Rate national benchmark sits near 90% generic / 10% brand for primary-care prescribers, per CMS Office of the Actuary 2024 estimates. Higher brand share is common in specialty prescribing where generic equivalents are not available.
Medicare Part D Prescribing Data
CMS Medicare Part D prescriber-level data for calendar year 2023.
4,176
Total Claims
$1.6M
Total Drug Cost
398
Medicare Beneficiaries
Prescribing Breakdown
- 30-Day Fills
- 9,033
- Total Day Supply
- 267,657
- Brand vs Generic
- 48% brand / 46% generic
- Brand Drug Cost
- $1.5M
- Generic Drug Cost
- $54K
Patient Demographics
- Average Patient Age
- 70.3 years
- Avg HCC Risk Score
- 1.75
- Gender Split
- 66% female / 34% male
- Age Distribution
- <65: 76, 65-74: 186, 75-84: 117, 85+: 19
Top Prescribed Drugs (Medicare Part D)
Top drugs by claim count for calendar year 2023. Based on Medicare Part D data only.
What Mark Campbell, M.D. prescribes most
Top Medicare Part D drugs by claim count, 2023
- Levothyroxine Sodium
Levothyroxine Sodium
884 claims
- Synthroid 340
Synthroid
340 claims
- Metformin Hcl Er 151
Metformin Hcl Er
151 claims
- Ozempic 144
Ozempic
144 claims
- Novolog Flexpen 140
Novolog Flexpen
140 claims
- Atorvastatin Calcium 139
Atorvastatin Calcium
139 claims
- Metformin Hcl 135
Metformin Hcl
135 claims
- Unithroid 130
Unithroid
130 claims
| Drug | Claims |
|---|---|
| Levothyroxine Sodium | 884 |
| Synthroid Levothyroxine Sodium | 340 |
| Metformin Hcl Er Metformin Hcl | 151 |
| Ozempic Semaglutide | 144 |
| Novolog Flexpen Insulin Aspart | 140 |
| Atorvastatin Calcium | 139 |
| Metformin Hcl | 135 |
| Unithroid Levothyroxine Sodium | 130 |
| Rosuvastatin Calcium | 124 |
| Humalog Kwikpen U-100 Insulin Lispro | 123 |
* Counts below 11 are suppressed by CMS for patient privacy. Generic names shown where available from CMS Part D data.
More Endocrinology, Diabetes & Metabolism Physician in PA →
All providers in Pennsylvania →
Compare specialties →
Endocrinology, Diabetes & Metabolism Physician Overview
How Mark Campbell, M.D. fits within the Endocrinology, Diabetes & Metabolism Physician landscape nationally.
7,852
Endocrinology, Diabetes & Metabolism Physician Providers in US
54
States with Endocrinology, Diabetes & Metabolism Physician
2,639
Avg Claims per Provider
Mark Campbell, M.D.'s 4,176 claims are above the specialty average of 2,639.
Nearby Endocrinology, Diabetes & Metabolism Physician Providers in Pennsylvania
Other clinicians with the same primary specialty enrolled in Pennsylvania, drawn from the same CMS NPPES roster as Campbell.
Dr. Munira Abbasi
MD
Pittsburgh, PA
Dr. Jana Abraham
MD
Berwyn, PA
Dr. Rachel Abramczyk
DO
Parkesburg, PA
Dr. Michael Adler
M.D.
Lewisburg, PA
Shivani Agarwal
Philadelphia, PA
Compare Endocrinology, Diabetes & Metabolism Physician nationally: see state-by-state distribution →
Before you book an appointment
Use this federal record as your verification checklist, not as a recommendation.
- Confirm the NPI record is current in the official CMS registry, providers update their own NPPES details, and moves can lag. Verify this NPI
- Check the active license and any disciplinary history with the Pennsylvania medical board, federal registration is not a license check. Credential verification guide
- Weigh a second option: compare this provider with a nearby Endocrinology, Diabetes & Metabolism Physician peer on Medicare volume and prescribing patterns. Compare providers
Medicare Part D and MIPS figures describe practice patterns in federal programs only, they are not quality ratings, and PlainDoctor does not rate, rank, or recommend providers.
Healthcare Guides
Learn more about finding, verifying, and understanding healthcare providers.
How to Find a Doctor
Step-by-step guide to choosing a provider
Verify Credentials
Check NPI, board certification & license status
Medical Specialties Explained
Who treats what and how specialties differ
Understanding Medicare Claims Data
What prescribing data reveals about a provider
In-Network vs Out-of-Network
How insurance networks affect your costs
Telehealth Guide
Virtual care options and coverage in 2026
Explore Pennsylvania
Frequently Asked Questions
What is Mark Campbell, M.D.'s specialty? ▼
Mark Campbell, M.D. specializes in Endocrinology, Diabetes & Metabolism Physician and practices in Altoona, Pennsylvania. Credentials: M.D..
How much does Mark Campbell, M.D. prescribe under Medicare Part D? ▼
In 2023, Mark Campbell, M.D. wrote 4,176 Medicare Part D claims totaling $1.6M in drug costs for 398 beneficiaries.
Where is Mark Campbell, M.D. located? ▼
Mark Campbell, M.D. is located at 615 HOWARD AVE, Altoona, PA, 16601. Phone: (814) 949-2950.
What is Mark Campbell, M.D.'s NPI number? ▼
Mark Campbell, M.D.'s National Provider Identifier (NPI) is 1306841952, issued on 06/20/2005.
Does Mark Campbell, M.D. prescribe more brand-name or generic drugs? ▼
Mark Campbell, M.D.'s prescribing is 48% brand-name and 46% generic drugs by claim count, with $1.5M in brand drug costs.
How many Endocrinology, Diabetes & Metabolism Physician providers are there in the US? ▼
There are 7,852 Endocrinology, Diabetes & Metabolism Physician providers across 54 states in the US. The average Endocrinology, Diabetes & Metabolism Physician provider writes 2,639 Medicare Part D claims per year.
What drugs does Mark Campbell, M.D. prescribe most often? ▼
Based on 2023 Medicare Part D data, Mark Campbell, M.D.'s most frequently prescribed drugs include Levothyroxine Sodium, Synthroid, Metformin Hcl Er. This reflects Medicare Part D prescriptions only and does not include commercial insurance or other payer types.
Does Mark Campbell, M.D. accept Medicare? ▼
Mark Campbell, M.D. appears in CMS Medicare data with 4,176 Part D claims and 398 Medicare beneficiaries in 2023. Contact the provider's office directly to confirm current Medicare enrollment and accepted plans.
How can I verify Mark Campbell, M.D.'s credentials? ▼
Mark Campbell, M.D.'s NPI is 1306841952 with credentials M.D.. You can verify this through the NPPES NPI Registry, check state medical board records, and confirm board certification through the ABMS or AOA.
Data Sources
View source datasets and methodology notes
- Provider Directory
- CMS National Plan and Provider Enumeration System (NPPES), download.cms.gov/nppes, updated monthly. Contains NPI, specialty, credentials, and practice location.
- Specialty Classification
- NUCC Health Care Provider Taxonomy (nucc.org), the industry standard for classifying provider specialties in Medicare and Medicaid billing.
- Prescribing Data
- CMS Medicare Part D Prescriber Public Use File (2023). Includes claims, drug costs, beneficiaries, and opioid prescribing rates.
- Limitations
- Provider data is self-reported to CMS. Prescribing data reflects Medicare Part D only and does not include commercial insurance, Medicaid, or cash prescriptions. Claims below 11 beneficiaries are suppressed by CMS for privacy.
See our complete data methodology for details on how we collect and process government data.
Data as of April 2026 (NPPES) / 2023 (Medicare Part D). Source: Centers for Medicare & Medicaid Services (CMS).
Disclaimer: Data from CMS NPPES and Medicare Part D. PlainDoctor does not rate or rank providers. Provider information is self-reported and may not be current. Always verify information directly with the provider. About · Methodology
Compiled from official public sources by the PlainDoctor editorial team.